# Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign

Study · id `cardio:ct-nct02625948` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02625948](<https://clinicaltrials.gov/study/NCT02625948>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02625948

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

## Technical summary

Registry record NCT02625948. Randomized; quadruple masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT02625948, source copy `cardio:ctgov-nct02625948-2016-09-14`, retrieved 2026-10-26)
- Start date: 2015-09 (registry gives no type) (ClinicalTrials.gov record NCT02625948, source copy `cardio:ctgov-nct02625948-2016-09-14`, retrieved 2026-10-26)
- Primary completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02625948, source copy `cardio:ctgov-nct02625948-2016-09-14`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: China (ClinicalTrials.gov record NCT02625948, source copy `cardio:ctgov-nct02625948-2016-09-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02625948-2016-09-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
- Acronym: TRAIGE
- Condition: Intracerebral Hemorrhage
- Condition: Stroke
- Intervention (Drug): Tranexamic Acid
- Lead sponsor: Ministry of Science and Technology of the People´s Republic of China
- Lead sponsor class: OTHER\_GOV
- Collaborator: Beijing Municipal Science & Technology Commission
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Ministry of Science and Technology of the People´s Republic of China (`cardio:org-ministry-of-science-and-technology-of-the-people-s-republic-dda658`)
- Registry lists this organization as a collaborator: Beijing Municipal Science & Technology Commission (`cardio:org-beijing-municipal-science-technology-commission`)

## Provenance

Content hash: 036e3a173fe57759b6b222d9e5863b5e65188eec2f37c7c2e308029a97c39068
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
